Nobutoshi Sugiyama

671 total citations
17 papers, 553 citations indexed

About

Nobutoshi Sugiyama is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Cancer Research. According to data from OpenAlex, Nobutoshi Sugiyama has authored 17 papers receiving a total of 553 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 8 papers in Cardiology and Cardiovascular Medicine and 5 papers in Cancer Research. Recurrent topics in Nobutoshi Sugiyama's work include Blood Coagulation and Thrombosis Mechanisms (9 papers), Atrial Fibrillation Management and Outcomes (6 papers) and Protease and Inhibitor Mechanisms (4 papers). Nobutoshi Sugiyama is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (9 papers), Atrial Fibrillation Management and Outcomes (6 papers) and Protease and Inhibitor Mechanisms (4 papers). Nobutoshi Sugiyama collaborates with scholars based in Japan, United States and Germany. Nobutoshi Sugiyama's co-authors include Taketoshi Furugohri, Y Morishima, Toshiro Shibano, Yuko Honda, K. Isobe, Takayasu Nagahara, Igor F. Tsigelny, Steven M. Sine, Palmer Taylor and Yasushi Abiko and has published in prestigious journals such as Blood, Biophysical Journal and European Journal of Pharmacology.

In The Last Decade

Nobutoshi Sugiyama

17 papers receiving 542 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nobutoshi Sugiyama Japan 9 305 199 172 128 60 17 553
Felix Schiele Germany 9 389 1.3× 283 1.4× 72 0.4× 169 1.3× 71 1.2× 13 682
Akiko Hijikata‐Okunomiya Japan 13 60 0.2× 52 0.3× 178 1.0× 132 1.0× 79 1.3× 38 477
Mu-Peng Li China 11 112 0.4× 22 0.1× 34 0.2× 92 0.7× 47 0.8× 27 332
Anish V. Sharda United States 11 48 0.2× 39 0.2× 69 0.4× 104 0.8× 22 0.4× 21 361
Sidney G. White United States 7 60 0.2× 25 0.1× 183 1.1× 54 0.4× 68 1.1× 11 486
Hans P. Deigner Germany 8 67 0.2× 19 0.1× 32 0.2× 134 1.0× 117 1.9× 10 376
Britta Walker-Allgaier Germany 7 145 0.5× 16 0.1× 47 0.3× 73 0.6× 28 0.5× 7 256
Andaleb Kholmukhamedov United States 8 44 0.1× 15 0.1× 67 0.4× 91 0.7× 26 0.4× 17 264
Annika Janefeldt Sweden 9 98 0.3× 61 0.3× 31 0.2× 75 0.6× 45 0.8× 11 392
S Formisano Italy 10 67 0.2× 5 0.0× 52 0.3× 145 1.1× 92 1.5× 24 469

Countries citing papers authored by Nobutoshi Sugiyama

Since Specialization
Citations

This map shows the geographic impact of Nobutoshi Sugiyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobutoshi Sugiyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobutoshi Sugiyama more than expected).

Fields of papers citing papers by Nobutoshi Sugiyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobutoshi Sugiyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobutoshi Sugiyama. The network helps show where Nobutoshi Sugiyama may publish in the future.

Co-authorship network of co-authors of Nobutoshi Sugiyama

This figure shows the co-authorship network connecting the top 25 collaborators of Nobutoshi Sugiyama. A scholar is included among the top collaborators of Nobutoshi Sugiyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobutoshi Sugiyama. Nobutoshi Sugiyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Shimizu, Takako, et al.. (2015). Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the Novel Factor Xa Inhibitor DY-807f in Healthy Volunteers. Thrombosis Research. 135(4). 594–601. 1 indexed citations
2.
Sugiyama, Nobutoshi, Y Morishima, Toshiro Shibano, & Taketoshi Furugohri. (2011). Antithrombin-independent thrombin inhibitors, but not direct factor Xa inhibitors, enhance thrombin generation in plasma through inhibition of thrombin-thrombomodulin-protein C system. Thrombosis and Haemostasis. 106(12). 1076–1083. 49 indexed citations
3.
Furugohri, Taketoshi, K. Isobe, Yuko Honda, et al.. (2008). DU‐176b, a potent and orally active factor Xa inhibitor: in vitro and in vivo pharmacological profiles. Journal of Thrombosis and Haemostasis. 6(9). 1542–1549. 246 indexed citations
4.
5.
Furugohri, Taketoshi, et al.. (2005). Different antithrombotic properties of factor Xa inhibitor and thrombin inhibitor in rat thrombosis models. European Journal of Pharmacology. 514(1). 35–42. 34 indexed citations
6.
7.
8.
9.
10.
Ikeda, Toshiko, et al.. (1998). Probucol treatment attenuates the aortic atherosclerosis in Watanabe heritable hyperlipidemic rabbits. Atherosclerosis. 137(1). 13–22. 28 indexed citations
11.
Sugiyama, Nobutoshi, Hideo Sugie, Yasuhito Igarashi, Masayasu Ito, & Thiago Yukio Fukuda. (1998). [Low-dose levodopa therapy of autistic disorder: evaluation of clinical effectiveness].. PubMed. 30(1). 51–5. 4 indexed citations
12.
Tsigelny, Igor F., Nobutoshi Sugiyama, Steven M. Sine, & Palmer Taylor. (1997). A model of the nicotinic receptor extracellular domain based on sequence identity and residue location. Biophysical Journal. 73(1). 52–66. 71 indexed citations
13.
Sugiyama, Nobutoshi, Santica M. Marcovina, A M Gown, et al.. (1992). Immunohistochemical distribution of lipoprotein epitopes in xanthomata from patients with familial hypercholesterolemia.. PubMed. 141(1). 99–106. 21 indexed citations
14.
Sugiyama, Nobutoshi, Takashi Sasaki, Masahiro Iwamoto, & Yasushi Abiko. (1988). Binding site of α2-plasmin inhibitor to plasminogen. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 952(1). 1–7. 45 indexed citations
15.
Sugiyama, Nobutoshi, Masahiro Iwamoto, & Yasushi Abiko. (1987). Effects of kringles derived from human plasminogen on fibrinolysis in vitro. Thrombosis Research. 47(4). 459–468. 15 indexed citations
16.
17.
Kawasaki, Koichi, et al.. (1985). Amino acids and peptides. VI. Synthesis of the N-terminal pentapeptide of .ALPHA.2-plasmin inhibitor and its analogue.. Chemical and Pharmaceutical Bulletin. 33(8). 3484–3487. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Felix Schiele Breakdown of academic impact, for papers by Akiko Hijikata‐Okunomiya Breakdown of academic impact, for papers by Mu-Peng Li Breakdown of academic impact, for papers by Anish V. Sharda Breakdown of academic impact, for papers by Sidney G. White Breakdown of academic impact, for papers by Hans P. Deigner Breakdown of academic impact, for papers by Britta Walker-Allgaier Breakdown of academic impact, for papers by Andaleb Kholmukhamedov Breakdown of academic impact, for papers by Annika Janefeldt Breakdown of academic impact, for papers by S Formisano
Rankless by CCL
2026